These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24112311)

  • 1. Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?
    Khanal A; Castelino RL; Peterson GM; Jose MD
    Intern Med J; 2014 Jan; 44(1):77-85. PubMed ID: 24112311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal drug dosing recommendations: evaluation of product information for brands of the same drug.
    Khanal A; Peterson GM; Castelino RL; Jose MD
    Intern Med J; 2014 Jun; 44(6):591-6. PubMed ID: 24946814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic comparison of four sources of drug information regarding adjustment of dose for renal function.
    Vidal L; Shavit M; Fraser A; Paul M; Leibovici L
    BMJ; 2005 Jul; 331(7511):263. PubMed ID: 15905228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.
    Park EJ; Wu K; Mi Z; Dong T; Lawrence JP; Ko CW; Huang SM; Zhang L; Crentsil V; Zhang J; Xu NN
    Ann Pharmacother; 2012 Sep; 46(9):1174-87. PubMed ID: 22932303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
    Lalonde RL; Wagner JA
    Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    Getachew H; Tadesse Y; Shibeshi W
    BMC Nephrol; 2015 Oct; 16():158. PubMed ID: 26446847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug dosing in patients with renal insufficiency in a hospital setting using electronic prescribing and automated reporting of estimated glomerular filtration rate.
    Nielsen AL; Henriksen DP; Marinakis C; Hellebek A; Birn H; Nybo M; Søndergaard J; Nymark A; Pedersen C
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):407-13. PubMed ID: 24373255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources.
    Bicalho MD; Soares DB; Botoni FA; Reis AM; Martins MA
    Int J Environ Res Public Health; 2015 Sep; 12(9):11227-40. PubMed ID: 26371029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strength of evidence for labeled dosing recommendations in renal impairment.
    Gagne JJ; Khan NF; Raj TS; Patel LR; Choudhry NK
    Clin Trials; 2017 Apr; 14(2):219-221. PubMed ID: 27780884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.
    Velenosi TJ; Urquhart BL
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine.
    Sweileh WM; Janem SA; Sawalha AF; Abu-Taha AS; Zyoud SH; Sabri IA; Al-Jabi SW; Jaradat NA; Zaid AA
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):908-12. PubMed ID: 17464934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with dosing guidelines in patients with chronic kidney disease.
    Long CL; Raebel MA; Price DW; Magid DJ
    Ann Pharmacother; 2004 May; 38(5):853-8. PubMed ID: 15054147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug dosing in patients with renal insufficiency. A simplified approach.
    Bakris GL; Talbert R
    Postgrad Med; 1993 Dec; 94(8):153-6, 159-60, 163-4. PubMed ID: 8247992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug dosage adjustment in patients with renal impairment and evaluation of renal function: focus on the cardiologic patients].
    Zimner-Rapuch S; Amet S; Janus N; Deray G; Launay-Vacher V
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):1-8. PubMed ID: 24856657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal antimicrobial drug exposure in patients with renal impairment.
    Czock D; Spitaletta M; Keller F
    Int J Clin Pharm; 2015 Oct; 37(5):906-16. PubMed ID: 26017400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to adjust the dose of drugs in chronic kidney disease?].
    Launay-Vacher V; Janus N; Zimner-Rapuch S; Amet S; Deray G
    Rev Prat; 2012 Mar; 62(3):309-11, 314-5. PubMed ID: 22514978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease.
    Tortorici MA; Cutler DL; Hazra A; Nolin TD; Rowland-Yeo K; Venkatakrishnan K
    J Clin Pharmacol; 2015 Mar; 55(3):241-50. PubMed ID: 25501531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative approach to drug dosing in chronic kidney disease.
    Olyaei AJ; Steffl JL
    Blood Purif; 2011; 31(1-3):138-45. PubMed ID: 21228582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.